New method for estimating HIV incidence and time from infection to diagnosis using HIV surveillance data:results for France

Ndawinz, Jacques D. A; Costagliola, Dominique; Supervie, Virginie.
AIDS ; 25(15): 1905-1913, 2011. tab, graf
Artículo en Inglés | BVSCARGA, FIOCRUZ | ID: car-731

Documentos relacionados

  1. Optimised prevention of postnatal HIV transmission in Zambia and Burkina Faso (PROMISE-EPI): a phase 3, open-label, randomised controlled trial.
  2. Patterns of Pre-exposure Prophylaxis (PrEP) Use in a Population Accessing PrEP in Jackson, Mississippi.
  3. Understanding gender differences of people with HIV newly diagnosed or returning to care with advanced HIV disease in Malawi: a qualitative study.
  4. Impact of increased antiretroviral therapy use during the treatment as prevention era in Australia.
  5. Initiation of HIV pre-exposure prophylaxis among youth in the United States, 2015-2018.
  6. Does HIV index testing bring patients into treatment at earlier stages of HIV disease? Results from a retrospective study in Ukraine.
  7. Impact of national commissioning of pre-exposure prophylaxis (PrEP) on equity of access in England: a PrEP-to-need ratio investigation.
  8. Comparative Effectiveness of Interventions to Improve the HIV Continuum of Care and HIV Preexposure Prophylaxis in Kenya: A Model-Based Analysis.
  9. Factors Influencing Rapid Antiretroviral Therapy Initiation at Four eThekwini Clinics, KwaZulu-Natal, South Africa.
  10. Adherence and persistence of HIV pre-exposure prophylaxis use in the United States.